Guangzhou, China

Fuchun Cao

This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Ac Pharmaceuticals Co., Ltd. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fuchun Cao. Retrieved from https://idiyas.com/inventor/fuchun-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fuchun Cao: Innovator in Drug Delivery Systems

Introduction

Fuchun Cao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to sustained-release microparticles and targeted hydrophobic anti-tumor drug formulations. With a total of 2 patents, his work is paving the way for advancements in pharmaceutical technology.

Latest Patents

Cao's latest patents include a preparation method of sustained-release microparticles. This invention allows for the entire preparation process to occur at normal or low temperatures, which is particularly beneficial for high-temperature-sensitive drugs such as proteins, nucleic acids, and peptides. The bioactivity of the active substances is preserved throughout the process, resulting in microparticles that exhibit an excellent sustained-release effect. This method addresses the common issues associated with conventional drug microparticle preparation, such as inconsistent drug release rates.

Another notable patent is the targeted hydrophobic anti-tumor drug nanoformulation and its preparation method. This formulation consists of a hydrophobic anti-tumor drug combined with a carrier in a specific mass ratio. The carrier is made up of albumin and a hyaluronic acid-albumin conjugate, which enhances the stability and efficacy of the nanoformulation. The preparation method ensures an even particle size distribution and high yield, making it a promising solution for targeted cancer therapies.

Career Highlights

Fuchun Cao is currently associated with Ac Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to improve drug delivery systems and enhance therapeutic outcomes for patients.

Collaborations

Cao collaborates with notable colleagues such as Yang Zheng and Feng Liu, contributing to a dynamic research environment that fosters innovation and development in drug formulation technologies.

Conclusion

Fuchun Cao's contributions to the field of drug delivery systems through his patents and collaborative efforts highlight his role as a key innovator in the pharmaceutical industry. His work not only addresses existing challenges but also opens new avenues for effective cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…